Home › IGA Glomerulonephritis › Ohio
IGA Glomerulonephritis clinical trials in Ohio
4 studies for IGA Glomerulonephritis are looking for participants at sites in Ohio.
Cities in Ohio
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Cincinnati Childrens Hospital MC, Cincinnati
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 21, 2026 · NCT07498335Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06989359Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- University Hospitals Cleveland Medical Center, Cleveland
- OSU Wexner Medical Center, Columbus
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Jul 29, 2026 · NCT06797518Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nationwide Children's Hospital, Columbus
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.